We employed a prevention model of antibody treatment in which 4-month old 5xFAD female mice received i.p. injections of 60 mg/kg of SKT82, DMR7, or isotype-matched IgG controls four days prior to unilateral injection of AD-tau into the hippocampus. Here, MAPT is linked to Alzheimer disease.